Loncar Cancer Immunotherapy ETF (NQ: CNCR )

32.29 USD +0.17 (+0.51%)

Official Closing Price Updated: 4:00 PM EST, Dec 4, 2020 Add to My Watchlist

Price and Volume

Volume	2,400
Open	32.06
Bid (Size)	32.33 (49)
Ask (Size)	35.00 (50)
Prev. Close	32.12
Today's Range	32.06 - 32.32
52wk Range	12.00 - 33.19
Shares Outstanding	2,400,000
Dividend Yield	1.08%

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

As U.K. Authorizes Pfizer Vaccine, Biotech ETFs Continue to Rally

December 03, 2020

Both stock index ETFs and biotech stocks and ETFs have been on a tear lately thanks to promising coronavirus vaccine developments from several major pharmaceutical companies. But this week, the U.K....

How Will Vaccine Arrivals Affect Biotech ETFs?

November 30, 2020

November has been a big month for stock and biotech ETFs, and with the Federal Aviation Administration announcing that it supported the “first mass air shipment” of coronavirus vaccines on Friday,...

Performance

YTD	+37.65%	+37.65%
1 Month	+13.94%	+13.94%
3 Month	+29.44%	+29.44%
6 Month	+24.94%	+24.94%
1 Year	+38.04%	+38.04%

More News

Biotech ETFs Remain Hot As Investors Await Upcoming Vaccine

November 27, 2020

Biotech ETFs Poised for Gains after Moderna Vaccine News

November 16, 2020

Will Moderna Vaccine News Boost Biotech ETFs?

November 12, 2020

This Week's Top Performing ETFs: 09/20/2020

September 21, 2020

This Week's Top Performing ETFs: 09/13/2020

September 14, 2020

6 Sector ETFs Surviving the Market Rout

September 15, 2020

5 ETFs Jump After Three-Day Rout: Will The Rally Last?

September 10, 2020

Moderna Vaccine Optimism Could Drive Biotech ETFs

August 26, 2020

Moderna ETFs To Gain On New Positive COVID-19 Vaccine Data

August 28, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.